Ubs Oconnor LLC Agenus Inc Transaction History

Ubs Oconnor LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $116,119 - $210,120	184,316 Added 12.76%	1,628,394 $1.35 Million
Q3 2023 Nov 14, 2023	BUY	$1.12 - $1.88 $33,600 - $56,400	30,000 Added 2.12%	1,444,078 $1.63 Million
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $1.85 Million - $2.88 Million	1,414,078 New	1,414,078 $2.26 Billion
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $65,830 - $133,930	45,400 Added 3.73%	1,263,403 $1.92 Million
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $888,812 - $1.43 Million	440,006 Added 56.56%	1,218,003 $0
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $157,005 - $251,529	80,105 Added 11.48%	777,997 $1.6 Billion
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.64 $343,059 - $696,674	263,892 Added 60.8%	697,892 $1.35 Million
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $1.02 Million - $1.51 Million	434,000 New	434,000 $1.07 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.